Assessment of Qualitative and Quantitative Parameters of Siddha Antipyretic Drug Astabhairava Mathirai based on PLIM Guidelines
DOI:
https://doi.org/10.38150/sajeb.15(3).p121-130Keywords:
Astabhairava Mathirai, PLIM Guideline, Antipyretic drug, Siddha medicine, StandardizationAbstract
According to Siddha pathology fever is classified as 64 types based on origin. Astabhairava Mathirai (ABM) is a Siddha metallo-mineral formulation traditionally used to treat 64 types of fever. Despite its historical significance, scientific validation of its safety is crucial for its acceptance in modern medicine. This study aims to assess the quality parameters of Asta bhairava mathirai based on PLIM Guidelines. The Astabhairava Mathirai was subjected to physiochemical analysis, Biochemical analysis, HPTLC and safety analysis like aflatoxin, pesticide residue, Microbial contamination, and heavy metals. The physicochemical analysis showed total ash (6.76%), acid-insoluble ash (1.14 %), pH (3.23), friability (0.020%), Water Extractive (26.95%), Alcohol Extractive (32.84%), hardness (1.0 kg/cm2), disintegration time (45 minutes). The biochemical analysis showed the presence of sulphide, sodium, iron, calcium, reducing sugar, and alkaloid. The safety studies viz., aflatoxin, pesticide residue, microbial contamination and heavy metals analysis revealed that the test drug ABM is within the AYUSH permissible limits. The HPTLC analysis showed the presence of 10 versatile phytochemical. Thus, the study reveals that the Astabhairava Mathirai has significant quality and safety. Consequently, these parameters can serve in the study of Astabhairava Mathirai as an important Siddha medicinal preparation among the scientific forum.



